SCHEMBL6619451

SCHEMBL6619451

NCCCN1CCC(C(O)(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 6/20 0.64
KCNH2 Q12809 5/20 0.63
CYP2J2 P51589 3/20 0.59
MEN1 O00255 2/20 0.59
NPC1 O15118 1/20 0.59
CACNA1F O60840 1/20 0.59
GMNN O75496 1/20 0.59
USP2 O75604 1/20 0.59
EGFR P00533 1/20 0.59
LMNA P02545 1/20 0.59
CYP1A2 P05177 1/20 0.59
FYN P06241 1/20 0.59
CHRM2 P08172 1/20 0.59
ABCB1 P08183 1/20 0.59
CYP3A4 P08684 1/20 0.59
HTR1A P08908 1/20 0.59
ADRA2A P08913 1/20 0.59
ADORA3 P0DMS8 1/20 0.59
GAA P10253 1/20 0.59
CYP2D6 P10635 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5728902 0.96 HRH1 (0.67) HRH1KCNH2CYP2J2MEN1NPC1
SCHEMBL10479209 0.91 HRH1 (0.63) HRH1KCNH2
SCHEMBL9786914 0.87 HRH1 (0.66) HRH1KCNH2CYP2J2MEN1
SCHEMBL16291199 0.85 KCNH2 (0.67) HRH1KCNH2CYP2J2MEN1NPC1
SCHEMBL5694766 0.85 HRH1 (0.68) HRH1KCNH2CYP2J2MEN1
SCHEMBL11872078 0.84 HRH1 (0.67) HRH1KCNH2CYP2J2MEN1
SCHEMBL55533 0.82 HRH1 (0.67) HRH1KCNH2CYP2J2CYP3A4
SCHEMBL10460762 0.82 KCNH2 (0.86) HRH1KCNH2CYP2J2MEN1KMT2A
SCHEMBL9076527 0.81 KCNH2 (0.84) HRH1KCNH2CYP2J2MEN1NPC1
SCHEMBL18590352 0.81 KCNH2 (0.84) HRH1KCNH2CYP2J2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979231-B1 CONDENSED PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-11-24 EP disclosed
EP-1123936-B1 FUSED PYRIDAZINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-12-10 EP disclosed
US-6627630-B1 Preventing or treating allergic skin diseases such as contact dermatitis, pruritus, dried dermatitis, acute urticaria prurigo and antiallergins TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1243271-A1 NASAL DROPS CONTAINING FUSED PYRIDAZINE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2002-09-25 EP disclosed
EP-1123936-A1 FUSED PYRIDAZINE DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-08-16 EP disclosed
US-6248740-B1 FOR SUPPRESSION OF HISTAMINE OR EOSINOPHIL CHEMOTAXIS TO TREAT ASTHMA; ANTIALLERGENIC TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-19 US disclosed
EP-0979231-A1 CONDENSED PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 2000-02-16 EP disclosed
WO-1998049167-A1 CONDENSED PYRIDAZINE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-11-05 WO disclosed
US-5470851-A Antihistamine, anticoagulants SANKYO COMPANY, LIMITED (JP) 1995-11-28 US disclosed
EP-0444156-A4 METHOD FOR TREATING VASCULAR DISEASES 1992-12-09 EP disclosed
CN-1058780-A Has the active thiazolidine carboxylic acid amides derivative of anti-allergy, their preparation and application SANKYO CO (JP) 1992-02-19 CN disclosed
EP-0463873-A1 Thiazolidinecarboxylic acid amide derivatives having anti-allergic activity, their preparation and their use Sankyo Company Limited (JP) 1992-01-02 EP disclosed
EP-0444156-A1 METHOD FOR TREATING VASCULAR DISEASES ABBOTT LABORATORIES (US) 1991-09-04 EP disclosed